All In MedTech

FDA Clearance Tracker · P970004-S082

INTERSTIM THERAPY TINED LEADS, MODELS 3889 AND 3093

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 2, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 2, 2010

Approved

Time to decision

59 days

Received Feb 2, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P970004-S082
Device name
INTERSTIM THERAPY TINED LEADS, MODELS 3889 AND 3093
Applicant location
Minneapolis, MN
Received
Feb 2, 2010
Decided
Apr 2, 2010
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P970004

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.